Showing 1407 results
-
Press release /Entresto (sacubitril/valsartan) demonstrated greatest benefit in HFpEF patients with ejection fractions adjacent to HFrEF, compared to valsartan1 Entresto, compared to valsartan, demonstrated…
-
Story /Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.
-
Story /Phil Gotwals talks about his vision for the future of business development for research.
-
Story /The most lethal strain could be eliminated by 2030, but major hurdles remain.
-
Story /How Shannon Campbell, Senior Vice President & Franchise Head at Novartis Oncology, came into her current role and leadership position.
-
Story /Survey results highlight the need for concerted action to guard against a fresh upsurge in the disease.
-
Story /Eyesight initiatives are restoring vision – and hope – to thousands of people in Southeast Asia by expanding equitable access to eye care.
-
Story /New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.
-
Ad hoc release /Der Nettoumsatz steigt um 5% (kWk[1], +7% USD), vor allem dank folgender Beiträge: Cosentyx erreicht USD 701 Millionen (+40% kWk) mit starken Zuwächsen bei allen Indikationen in den USA und der…